摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(azidomethyl)-4,5-diphenyloxazole | 1401734-75-5

中文名称
——
中文别名
——
英文名称
2-(azidomethyl)-4,5-diphenyloxazole
英文别名
2-azidomethyl-4,5-diphenyloxazole;2-(Azidomethyl)-4,5-diphenyl-1,3-oxazole;2-(azidomethyl)-4,5-diphenyl-1,3-oxazole
2-(azidomethyl)-4,5-diphenyloxazole化学式
CAS
1401734-75-5
化学式
C16H12N4O
mdl
——
分子量
276.297
InChiKey
BUFNZKTWFGIMTH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    40.4
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(azidomethyl)-4,5-diphenyloxazole4-戊基苯乙炔copper(ll) sulfate pentahydratesodium ascorbate 作用下, 以 四氢呋喃 为溶剂, 反应 16.0h, 以94%的产率得到4-(4-pentylphenyl)-1-((4,5-diphenyloxazol-2-yl)methyl)-1H-1,2,3-triazole
    参考文献:
    名称:
    1,2,3-Triazole-based inhibitors of Porphyromonas gingivalis adherence to oral streptococci and biofilm formation
    摘要:
    The development and use of small-molecule inhibitors of the adherence of Porphyromonas gingivalis to oral streptococci represents a potential therapy for the treatment of periodontal disease as these organisms work in tandem to colonize the oral cavity. Earlier work from these laboratories demonstrated that a small synthetic peptide was an effective inhibitor of the interaction between P. gingivalis and Streptococcus gordonii and that a small-molecule peptidomimetic would provide a more stable, less expensive and more effective inhibitor. An array of 2-(azidomethyl)- and 2-(azidophenyl)-4,5-diaryloxazoles having a full range of hydrophobic groups were prepared and reacted with substituted arylacetylenes to afford the corresponding 'click' products. The title compounds were evaluated for their ability to inhibit P. gingivalis' adherence to oral streptococci and several were found to be inhibitory in the range of (IC50) 5.3-67 mu M. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.orgilicensesiby-nc-nd/4.0/).
    DOI:
    10.1016/j.bmc.2016.08.059
  • 作为产物:
    描述:
    2-(chloromethyl)-4,5-diphenyloxazole 在 sodium azide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 3.0h, 生成 2-(azidomethyl)-4,5-diphenyloxazole
    参考文献:
    名称:
    单击化学的恶唑II:扩展杂环骨架的合成。
    摘要:
    建立了形成2、4、5-三取代的恶唑的新途径,从而通过起始的不对称酰基胞苷的结构建立了取代模式。通过改进先前描述的方法制备2-氯甲基-4,5-二取代的恶唑,其中使用乙酸铵/乙酸方案将对称和不对称酰基的氯乙酰基酯环化。进行取代后,然后在温和条件下通过取代安装叠氮化物部分。尽管需要二溴化和碘化的苯基恶唑进行进一步的合成修饰,但发现环化反应对原料中卤素的相对位置非常敏感。
    DOI:
    10.1016/j.tetlet.2014.11.014
点击查看最新优质反应信息

文献信息

  • [EN] ANTI-BIOFILM COMPOUNDS<br/>[FR] COMPOSÉS ANTI-BIOFILM
    申请人:UNIV LOUISVILLE RES FOUND
    公开号:WO2013016206A1
    公开(公告)日:2013-01-31
    The present invention provides non-peptide compounds of formula (I) wherein: X is -(C1-C8)allcyl-, aryl or -aryl(C1-C8)alkyl-; Y is -(C1-C8)alkyl- or absent; W is heteroaryl, (C3-C7)carbocycle or aryl, wherein any heteroaryl, (C3-C7)carbocycle or, aryl of W is optionally substituted with one or more (e.g. 1, 2, 3, 4 or 5) Z1 groups; R1 is (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl or aryl, wherein aryl is optionally substituted with one or more (e.g. 1, 2, 3, 4 or 5) groups selected from (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C3-C7)carbocycle, halo(C1-C3)alkyl, -CN, NO2, halogen, -ORa, -SRa, -S(O)2NRbRc, -NRbRc, -NRaCORd, -C(O)Ra, -C(O)ORa, and -C(O)NRbRc; R2 is (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)Jalkynyl or aryl, wherein aryl is optionally substituted with one or more (e.g. 1, 2, 3, 4 or 5) groups selected from (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C3-C7)carbocycle, halo(C1-C3)alkyl, -CN, NO2, halogen, -ORe, -SRe, -S(O)2NRfRg, -NRfRg -NReCORh, -C(O)Re, -C(O)ORe and -C(O)NRfRg; I that mimic the streptococcal; SspB Adherence Region (BAR) and function as inhibitors of P. gingivalis adherence to streptococci. The invention also provides methods of making and using the inhibitors.
    本发明提供了式(I)的非肽化合物,其中:X为-(C1-C8)烷基,芳基或-芳基(C1-C8)烷基-;Y为-(C1-C8)烷基或不存在;W为杂环芳基,(C3-C7)碳环或芳基,其中W的任何杂环芳基,(C3-C7)碳环或芳基可以选择性地用一个或多个(Z1)基团取代;R1为(C1-C8)烷基,(C2-C8)烯基,(C2-C8)炔基或芳基,其中芳基可以选择性地用一个或多个(C1-C8)烷基,(C2-C8)烯基,(C2-C8)炔基,(C3-C7)碳环,卤代(C1-C3)烷基,-CN,NO2,卤素,-ORa,-SRa,-S(O)2NRbRc,-NRbRc,-NRaCORd,-C(O)Ra,-C(O)ORa和-C(O)NRbRc基团中的一个或多个取代;R2为(C1-C8)烷基,(C2-C8)烯基,(C2-C8)炔基或芳基,其中芳基可以选择性地用一个或多个(C1-C8)烷基,(C2-C8)烯基,(C2-C8)炔基,(C3-C7)碳环,卤代(C1-C3)烷基,-CN,NO2,卤素,-ORe,-SRe,-S(O)2NRfRg,-NRfRg,-NReCORh,-C(O)Re,-C(O)ORe和-C(O)NRfRg基团中的一个或多个取代;I模拟链球菌SspB粘附区(BAR)并作为P. gingivalis粘附于链球菌的抑制剂。该发明还提供了制备和使用这些抑制剂的方法。
  • Oxazoles for click chemistry II: synthesis of extended heterocyclic scaffolds
    作者:Pravin C. Patil、Frederick A. Luzzio、Donald R. Demuth
    DOI:10.1016/j.tetlet.2014.11.014
    日期:2015.6
    New routes to 2, 4, 5-trisubstituted oxazoles were established whereby the substitution pattern was established by the structure of the starting nonsymmetrical acyloins. 2-Chloromethyl-4, 5-disubstituted oxazoles were prepared by refinements of an earlier described process whereby chloroacetyl esters of symmetrical and non-symmetrical acyloins were cyclized using an ammonium acetate/acetic acid protocol
    建立了形成2、4、5-三取代的恶唑的新途径,从而通过起始的不对称酰基胞苷的结构建立了取代模式。通过改进先前描述的方法制备2-氯甲基-4,5-二取代的恶唑,其中使用乙酸铵/乙酸方案将对称和不对称酰基的氯乙酰基酯环化。进行取代后,然后在温和条件下通过取代安装叠氮化物部分。尽管需要二溴化和碘化的苯基恶唑进行进一步的合成修饰,但发现环化反应对原料中卤素的相对位置非常敏感。
  • ANTI-BIOFILM COMPOUNDS
    申请人:Demuth Donald R.
    公开号:US20140161845A1
    公开(公告)日:2014-06-12
    The present invention provides non-peptide compounds of formula (I) wherein: X is —(C 1 -C 8 )allcyl-, aryl or -aryl(C 1 -C 8 )alkyl-; Y is —(C 1 -C 8 )alkyl- or absent; W is heteroaryl, (C 3 -C 7 )carbocycle or aryl, wherein any heteroaryl, (C 3 -C 7 )carbocycle or, aryl of W is optionally substituted with one or more (e.g. 1, 2, 3, 4 or 5) Z 1 groups; R 1 is (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl or aryl, wherein aryl is optionally substituted with one or more (e.g. 1, 2, 3, 4 or 5) groups selected from (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, halo(C 1 -C 3 )alkyl, —CN, NO 2 , halogen, —OR a , —SR a , —S(O) 2 NR b R c , —NR b R c , —NR a COR d , —C(O)R a , —C(O)OR a , and —C(O)NR b R c ; R 2 is (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )Jalkynyl or aryl, wherein aryl is optionally substituted with one or more (e.g. 1, 2, 3, 4 or 5) groups selected from (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, halo(C 1 -C 3 )alkyl, —CN, NO 2 , halogen, —OR e , —SR e , —S(O) 2 NR f R g , —NR f R g —NR e COR h , —C(O)R e , —C(O)OR e and —C(O)NR f R g ; I that mimic the streptococcal; SspB Adherence Region (BAR) and function as inhibitors of P. gingivalis adherence to streptococci. The invention also provides methods of making and using the inhibitors.
    本发明提供了化合物(I)的非肽类衍生物,其中:X是—(C1-C8)烷基,芳基或-芳基(C1-C8)烷基-; Y是—(C1-C8)烷基或不存在; W是杂环芳基,(C3-C7)碳环或芳基,其中W的任何杂环芳基,(C3-C7)碳环或芳基可选择地用一个或多个(Z1)基团取代; R1是(C1-C8)烷基,(C2-C8)烯基,(C2-C8)炔基或芳基,其中芳基可选择地用一个或多个(C1-C8)烷基,(C2-C8)烯基,(C2-C8)炔基,(C3-C7)碳环,卤代(C1-C3)烷基,—CN,NO2,卤素,—ORa,—SRa,—S(O)2NRbRc,—NRbRc,—NRaCORd,—C(O)Ra,—C(O)ORa和—C(O)NRbRc基团中的一个或多个取代; R2是(C1-C8)烷基,(C2-C8)烯基,(C2-C8)炔基或芳基,其中芳基可选择地用一个或多个(C1-C8)烷基,(C2-C8)烯基,(C2-C8)炔基,(C3-C7)碳环,卤代(C1-C3)烷基,—CN,NO2,卤素,—ORe,—SRe,—S(O)2NRfRg,—NRfRg—NReCORh,—C(O)Re,—C(O)ORe和—C(O)NRfRg基团中的一个或多个取代; I模拟链球菌SspB粘附区(BAR),并作为P. gingivalis粘附到链球菌的抑制剂。本发明还提供制备和使用抑制剂的方法。
  • Preparation of azidoaryl- and azidoalkyloxazoles for click chemistry
    作者:Catherine M. Loner、Frederick A. Luzzio、Donald R. Demuth
    DOI:10.1016/j.tetlet.2012.08.032
    日期:2012.10
    A series of azidoaryl- and azidoalkyl(diphenyl)oxazole scaffolds were warranted for biofilm inhibition studies. Cyclization of azidoaryl- or azidoalkyl esters of benzoin with ammonium acetate in acetic acid gives 2-azidoaryl- or 2-azidoalkyl-4,5-diphenyloxazoles. The azidoaryl esters are prepared from the corresponding azidocarboxylic acids/acid chlorides while the azidoalkyl esters are prepared from the corresponding haloalkyl esters. (C) 2012 Elsevier Ltd. All rights reserved.
  • US9167820B2
    申请人:——
    公开号:US9167820B2
    公开(公告)日:2015-10-27
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺